comparemela.com

Canadian Cardiovascular Society News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Roche granted FDA Breakthrough Device Designation

Roche announces that the Tina-quant lipoprotein Lp(a) RxDx assay receives Breakthrough Device Designation from the FDA

Matt sauseEuropean atherosclerosis societyCanadian cardiovascular societyHeart societyEuropean society of cardiologyNational lipid associationDrug administrationProduct newsBreakthrough device designationEuropean societyBeijing heart society

Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk

Approximately one in five people worldwide have elevated Lp levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1The Roche Diagnostics.

United statesNathalie altermattJay bradnerSabine borngrKarsten kleineRebekka schnellSimon goldsboroughLoren kalmBirgit masjostKirti pandeyYvette petillonSileia urechBruno eschliColl cardiolMatt sauseRoche group

F Hoffmann-La Roche Ltd: Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) - a key marker for hereditary cardiovascular risk

Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1The Roche Diagnostics Tina-quant®

United statesMatt sauseSabine borngrKarsten kleineRebekka schnellSimon goldsboroughBirgit masjostYvette petillonJay bradnerNathalie altermattSileia urechLoren kalmKirti pandeyBruno eschliEuropean society of cardiologyCanadian cardiovascular society

FDA Grants Tina-qant Lp(a) Assay Breakthrough Device Designation

A lipoprotein (a) (Lp[a]) assay has been granted breakthrough device designation to expand identification of patients with elevated Lp(a) and genetic predispositions to cardiovascular disease.

United statesNational heartEuropean atherosclerosis societyBlood instituteAmerican heart associationCanadian cardiovascular societyDevice designationShow lepodisiran was well toleratedSubstantially lowered lipoproteinAmerican heartAccessed mayAdv exp med

Responders to PCI for Angina Relief Identified by Chest Pain Type

Typical angina predicted PCI's efficacy in ORBITA-2

United statesFrance generalCity ofUnited kingdomSamir alamRobert yehNicole louFlorentina simaderChristina lalaniColl cardiolImperial college londonBeth israel deaconess medical centerAmerican university of beirutHarvard medical schoolJournal of the american college cardiologyCanadian cardiovascular society

vimarsana © 2020. All Rights Reserved.